Literature DB >> 32790709

Impact of Wuhan lockdown on the indications of cesarean delivery and newborn weights during the epidemic period of COVID-19.

Min Li1, Heng Yin1, Zhichun Jin2, Huan Zhang1, Bingjie Leng1, Yan Luo1, Yun Zhao1.   

Abstract

OBJECTIVE: To prevent the rapid spread of COVID-19, the Chinese government implemented a strict lockdown in Wuhan starting on 23 January, 2020, which inevitably led to the changes in indications for the mode of delivery. In this retrospective study, we present the changes in the indications for cesarean delivery (CD) and the birth weights of newborns after the lockdown in Wuhan.
METHODS: A total of 3,432 pregnant women in the third trimester of their pregnancies who gave birth in our hospital from 23 January 2019 to 24 March 2020 were selected as the observation group, while 7,159 pregnant women who gave birth from 1 January 2019 to 22 January 2020 were selected as the control group; control group was matched using propensity score matching (PSM). A comparative analysis of the two groups was performed with the chi-square test, t test and rank sum test.
RESULTS: The difference in the overall rate of CD between the two groups was not statistically significant (p<0.05). Among the indications for CD, CD on maternal request (CDMR) and fetal distress were also significantly more common in the observation group (p<0.05) than the control group. Furthermore, we found that the weight of newborns was significantly heavier in the observation group than in the control group when considering full-term or close-to-full-term births (p<0.05).
CONCLUSIONS: The results may provide useful information to management practices regarding pregnancy and childbirth after lockdown in other cities or countries, enabling better control of the rate of CD due to CDMR, reducing fetal distress, and controlling newborn weight. We recommend that pregnant women pay more attention to controlling the weight of newborns through diet and exercise.

Entities:  

Mesh:

Year:  2020        PMID: 32790709      PMCID: PMC7425855          DOI: 10.1371/journal.pone.0237420

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

At the end of December 2019, a cluster of cases of coronavirus disease-2019 (COVID-19) were first reported in Wuhan, China [1]. On 23 January 2020, the municipal government of Wuhan announced the lockdown of the entire city, and China implemented a national emergency mechanism with different cities adopting different measures according to their respective situations. On 30 January 2020, the WHO declared COVID-19 to be a “public health emergency of international concern”, and the US recorded its first confirmed case of human-to-human transmission in Chicago [2, 3]. It is evident that the lockdown in Wuhan has played a critical role in limiting the scope of the COVID-19 epidemic in China. Since then, the life-threatening COVID-19 outbreak has become a global pandemic. By 5 April 2020, the global number of confirmed cases had exceeded 1.1 million, with a daily increase of approximately 0.1 million cases. To cope with this disaster, an increasing number of government agencies in the US and European countries have implemented lockdown policies to prevent the rapid spread of COVID-19. During the lockdown, city residents are required to refrain from leaving home and to practice social distancing. In the past two months, scholars began to pay attention to the management of pregnancy and childbirth during the COVID-19 pandemic. Previous studies have shown that pregnancy while infected with severe acute respiratory syndrome coronavirus (SARS-CoV) was associated with adverse maternal and neonatal complications, such as spontaneous miscarriage, preterm delivery, intrauterine growth restriction, the need for endotracheal intubation, admission to the intensive care unit, renal failure, and disseminated intravascular coagulopathy [4, 5]. Although the possible risks associated with COVID-19 and the clinical characteristics of pregnant women with laboratory-confirmed COVID-19 have been investigated [6, 7], previous research has failed to address the impact of lockdown during the COVID-19 epidemic. Unlike other activities that can be carried out online or at home, delivery cannot be delayed arbitrarily or performed at home. The lockdown in Wuhan may have a significant impact on the outcome of pregnancy due to pathological factors, the timeliness of examinations, psychological panic, limited medical resources, difficulty accessing and transportation, etc. An essential question that is important for obstetricians to consider is how does the lockdown affect the indications for different modes of delivery and newborn health? This study answers the question based on an analysis of the data from more than 10,000 cases from our working hospital in Wuhan, the Maternal and Child Hospital of Hubei Province, which has one of the largest obstetrics departments of all Chinese hospitals. The department delivered approximately 25,000 babies annually in the last five years. During the COVID-19 epidemic, our hospital was identified as a non-designated hospital with a fever clinic accept pregnant women who were not infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and those who were suspected of being infected. The latter patients who received laboratory-confirmation of infection via quantitative qPT-PCR for SARS-CoV-2 using a throat swab were transferred to designated hospitals for further treatment. During the lockdown in Wuhan, a total of 3,432 pregnant women underwent delivery in our birth center, and a few cases of COVID-19 were confirmed in pregnant women. In this study, we compared the indications for cesarean delivery (CD) and the birth weights of newborns born to 3,432 pregnant women who gave birth during lockdown and 7,159 propensity score-matched pregnant women who gave birth before the lockdown were selected as the control group.

Methods

Study design and patients

Fig 1 illustrates the subject selection process. Pregnant women who had given birth in the birth center of the Maternal and Child Health Hospital of Hubei Province from 23 January 2020 to 14 March 2020 were enrolled as the observation group. The age of the selected patients ranged from 18 to 50 years old. The exclusion criteria included a gestational age less than 28 weeks and intrauterine fetal death. A total of 3442 pregnant women were initially included, among whom 5 with gestational age less than 28 weeks of and 5 with intrauterine fetal death were excluded. The remaining 3432 patients constituted the observation group.
Fig 1

Population flow chart of the retrospective study.

From 29, 799 historical patients from 1 January 2019 to 22 January 2020, the control group included a total of 7,159 patients based on the propensity score matching (PSM) method as. The PSM method, a quasi-experimental design that has been used across disciplines to isolate treatment effects on a number of outcomes using observational data, was employed in this study to obtain matched patients to facilitate comparisons [8]. Based on three variables of age, gravidity, and parity, 7159 pregnant women were selected as the control group from the 29799 patients before the lockdown using the PSM method. The balanced scores of the two groups were 0.10312 and 0.10590, which were very similar.

Data collection

In our department, one nurse is responsible for the daily recording of the delivery information of all the pregnant women into the Electronic Medical Record System (EMRS). In this research, obstetricians extracted the required data, including epidemiological, demographic, clinical, laboratory, and pregnancy outcome data for both the observation group and control group. The neonates’ data including birth weight, clinical symptoms, Apgar score, and outcomes were also collected. During this period, all pregnant women with COVID-19 symptoms, such as fever, cough, and abnormal CT scan results, underwent nucleic acid detection of COVID-19 of SARS-COV02 from swab samples. In total, 13 pregnant women had confirmed COVID-19, including 8 pregnant women who underwent CD. Their throat swab samples were collected and sent to the local Chinese Center for Disease Control and Prevention (CDC), which was in charge of detecting SAS-COV-2 by qRT-PCR. The results for each woman suspected of having COVID-19 was entered into the EMRS.

Statistical methods

Statistical analysis was performed using SPSS 22.0. The chi-square test was used for the comparison of countable data. The t-test and Fisher’s exact probability method were used for the comparison of the means between the measurement data. The rank sum test was used for ranking variables. A difference was statistically significant at p<0.05.

Results

A comparison of the observation group and control group is shown in Table 1. There were no significant differences in maternal age, gravidity, parity history, or BMI between the two groups (p>0.05). At the same time, there were no differences in the proportions of preterm and term neonates between the two groups (p>0.05).
Table 1

Comparison of the general situation of pregnant women.

Before lockdown (n = 7159)After lockdown (n = 3432)Chi-squarep-value
No.%No.%
Age<356385893095902.430.12
≥357741133710
Gravida13288461544451.440.70
220032898129
311131652715
≥47541038011
ParaPrimipara4685652243650.010.93
Multiparas247435118935
BMI<256665933167922.350.16
≥2549472658
Preterm and term birthsPreterm615928180.490.47
Term654491315192
Table 2 shows the comparison of the rates of CD and vaginal delivery before and after lockdown. The data show that there was no significant difference between the two groups (p>0.05). In fact, the CD rate in the observation and control groups were 47.49% and 47.70%, respectively.
Table 2

CD rate and vaginal delivery rate before and after lockdown.

Before lockdown (n = 7159)After lockdown (n = 3432)Chi-squarep-value
No.%No.%
Vaginal delivery3759531795520.040.84
Cesarean delivery340047163748
Table 3 shows the comparison of the indications for CD. There were no significant differences in most of the pregnancy complications between the observation group and control group. The number of pregnant women who underwent CD due to fetal distress in the observation group was significantly higher than that in the control group (p<0.05). In addition, the incidence of CDMR in the observation group was significantly higher than that in the control group (p<0.05). CDMR was defined as a primary prelabor cesarean delivery performed on maternal request in the absence of any maternal or fetal indications [9]. In the observation group, 13 cases of COVID-19 were confirmed by chest CT scan and two positive laboratory tests for SARS-CoV-2 in throat swab samples. Eight of those 13 patients with confirmed COVID-19 underwent CD. There were 0 COVID-19 cases in the control group. The other indications for CD in the observation group were not significantly different than those in the control group.
Table 3

Comparison of the indications of CD.

Before lockdown (n = 3400)After lockdown (n = 1637)Chi-squarep-value
No.%No.%
Scar uterus112833553340.180.67
Fetal distress53715297184.41<0.05
Abnormal fetal position3381013783.200.07
Cesarean delivery on maternal request (CDMR)28481861111.83<0.05
Giant fetus21068352.470.12
Hypertension20567953.010.08
Multiple pregnancy13346840.170.68
Placenta previa9433222.970.09
Induction of labor failure7423020.650.42
Prenatal fever6922621.160.28
Labor abnormalities4612210.020.98
ICPb3711710.030.87
Placental abruption3311310.380.54
Diabetes3111210.420.52
Umbilical cord221502.420.12
Genital malformation1401313.030.08
FGRc110103.200.07
COVID-190080<0.05a
Others3411710.020.90

a△means Fisher's exact probability method, because the frequency of cells appears 0

bICP means intrahepatic cholestasis of pregnancy

cFGR means fetal growth restriction

a△means Fisher's exact probability method, because the frequency of cells appears 0 bICP means intrahepatic cholestasis of pregnancy cFGR means fetal growth restriction Neonatal asphyxia is divided into mild asphyxia and severe asphyxia, which are mainly evaluated based on the Apgar score. According to the Apgar score, a total score from 0 to 3 is classified as severe asphyxia, from 4 to 7 is classified as mildly asphyxiated, and from 8 to 10 is normal [10]. Table 4 shows that there was no significant difference in neonatal asphyxia between the two groups (p>0.05).
Table 4

Comparison result on neonatal asphyxia.

Neonatal asphyxiaz-valuep-value
NormalMildSevere
No.%No.%No.%
Before lockdown7097995111100.540.46
After lockdown34079919160
As shown in Table 5, the neonatal birth weight in the observation group was heavier than that in the control group among those with ≥34 gestational weeks (p<0.05). However, there was no significant difference among those with fewer than 34 gestational weeks (p>0.05).
Table 5

Newborn weight at different gestational age.

Newborn groupBefore lockdown (g)After lockdown (g)t-valuep-value
28 ≤ gestational age(wks) <321,462±3181479±231-0.260.80
32 ≤ gestational age(wks) < 341,926±3132,021±253-1.540.13
34 ≤ gestational age(wks) < 372,583±4242,652±3856-2.06<0.05
37 ≤ gestational age(wks) < 383,167±3853,207±398-2.95<0.05
gestational age(wks) ≥393,402±3703,426±384-2.32<0.05

Discussion

This paper presents a comparison of the indications for CD and newborn weights before and after the Wuhan lockdown. All the patients in the observation group and the control group were collected from the Maternal and Child Health Hospital of Hubei Province. During the lockdown to prevent the spread of the COVID-19 outbreak from 23 January 2020 to 13 March 2020, a total of 49,995 cases were confirmed in Wuhan with 2,446 deaths [11]. In our empirical study, the overall CD rate was not significant different between the observation group and the control group. The differences in most of the indications for CD between the observation group and control group were not significant. This may serve as reassurance to many pregnant women who are currently having to remain primarily at home that a lockdown is unlikely to dramatically affect complications of pregnancy. However, we empirically observed that the rate of CDMR increased significantly during this period. CDMR may reduce the risk of hemorrhage and transfusion, but is also potentially associated with a longer maternal hospital stay, an increased risk of respiratory problems for the infant, and the need for hysterectomy [9]. The main reason for the increase in the rate of CDMR was that the pregnant women in Wuhan were reluctant to wait for a natural birth due to fear of COVID-19 infection during hospitalization. After the city was locked down, 8 out of 13 pregnant women with confirmed COVID-19 underwent CD in our birth center. Severe COVID-19 was treated as an indication for CD according to the Chinese Expert Consensus [12]. If a pregnant woman had mild or asymptomatic COVID-19 and her cervix was dilated, vaginal delivery could be selected. If the fetus was in distress, the level of control of COVID-19 was unsatisfactory, or there were other indications for CD, CD was performed by obstetricians [13]. During the Wuhan lockdown, pregnant women had to remain in their homes, limiting their ability to exercise and attend appointments. They reduced the frequency of prenatal examinations because they were afraid of contracting COVID-19, and some pregnant women were never examined from the initiation of lockdown until delivery. Therefore, some important risk factors may not have been detected in a timely manner, leading to an increased incidence of fetal distress. Through the comparison of the observation group and the control group, we found that lockdown may have led to heavier newborns with a gestational age greater than 34 weeks. The possible underlying contributory factors might include food and nutrition changes and lack of exercise. During pregnancy, balanced nutrition and adequate intake of vegetables and protein have a positive impact on the birth weight of the neonate [14-16]. However, due to the COVID-19 in Wuhan, supermarkets and vegetable markets were closed, and access to nutrient-rich food was relatively restricted. The relative lack of vegetables and food high in crude fiber, and the increased intake of carbohydrate-rich foods, such as rice and noodles, which were easily obtained and stored, led to an increase in neonatal weight. In addition, after the city was locked down, pregnant women became less active and exercised less. We recommend that during a city lockdown due to COVID-19, pregnant women should try to eat a balanced diet, increasing their intake of protein and vegetables as much as possible and controlling their intake of carbohydrates such as rice noodles, and increase their engagement in indoor activities. Our research has some limitations. First, due to the reduction in or even absence of examinations of pregnant women, we could not collect the data on changes in body weight during this period. Second, the findings might have been affected by other factors, such as climate, food type, and other uncontrollable inputs, because the observation group was collected from a short period in 2020. The research question investigated in this study needs further exploration with other data sets. (XLSX) Click here for additional data file. 2 May 2020 Submitted filename: Response to Reviewers.docx Click here for additional data file. 1 Jun 2020 PONE-D-20-12899 The Influence of lockdown on the indications of cesarean delivery and newborn weights during the epidemic period of COVID-19 in Wuhan PLOS ONE Dear Dr. Zhao, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. This paper represents a resubmission of a previously submitted paper that was reviewed extensively. The authors were provided the opportunity to tone down their claims and ensure that throughout the paper it was clear that they are not examining how COVID-19 affects pregnancy outcomes or analyze such samples. They chose the former approach. The original reviewers have reviewed the revised paper and expressed conflicting recommendations. However, both agree that the work is not "blockbuster", but it may provide some comfort to pregnant women having to quarantine that it will not drastically affect their neonates. In reviewing the journal guidelines, it will allow for descriptive papers, such as this one. That being sad, it still needs to meet certain standards in terms of the English and previous and current reviewer concerns need to be addressed. It is recommended to have the revised manuscript proofed by an outside individual before it is resubmitted. Both reviewers have also provided helpful comments. Please submit your revised manuscript by Jul 16 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Cheryl S. Rosenfeld, DVM, PhD Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2.  We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. * In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This toned-down manuscript with a more accurate title is much improved. It might be helpful to have a reader fluent in English correct some of the minor grammatical and style errors, even though the narrative is easy to follow and is readily comprehensible. Overall, the paper sends a reassuring message to women confined to home during a pandemic. Reviewer #2: This is a revised version of a manuscript in which the authors report various metrics related to late pregnancy, Caesarian deliveries and other aspects of pregnancy in the Wuhan, China region during the pandemic. The manuscript has been improved, and a large number of problems identified by the reviewers have been addressed. There has been great interest in whether the infection of a pregnant mother would result in any changes in the fetus during late gestation or the infants after birth. Although the current study does not address this, the questions the authors do address have some value as well, but perhaps not enough to justify a publication in a broad and general interest journal like this. It seems like these types of data would be more appropriate for a specialty human journal that focused on Ob/Gyn, rather than a general interest journal like PLOS One. There are still a number of problems with the English. It was recommended in the initial review that the authors consider using this type of service, or get some other editorial help from a native English speaker. Just a few of the types of problems that occur in the manuscript are listed below; this is by no means a complete list. Line 114: you cannot start a sentence with a numeral in English. Line 120: SCORES Line 155: you cannot start a sentence with a numeral in English. Line 197: change “pregnant women were trapped in their homes” to “pregnant women were confined to their homes” Line 197-198: change “and it was not convenient for them to go out for taking a walk.” To “and their ability to exercise was limited.” Tables 1, 3 and 4: The authors should review rules on significant digits. It does not seem correct to show the percentage values with two places to the right of the decimal. Would not whole percentages perhaps be better? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 30 Jun 2020 Response to Editor Q1. This paper represents a resubmission of a previously submitted paper that was reviewed extensively. The authors were provided the opportunity to tone down their claims and ensure that throughout the paper it was clear that they are not examining how COVID-19 affects pregnancy outcomes or analyze such samples. They chose the former approach. The original reviewers have reviewed the revised paper and expressed conflicting recommendations. However, both agree that the work is not "blockbuster", but it may provide some comfort to pregnant women having to quarantine that it will not drastically affect their neonates. In reviewing the journal guidelines, it will allow for descriptive papers, such as this one. That being sad, it still needs to meet certain standards in terms of the English and previous and current reviewer concerns need to be addressed. It is recommended to have the revised manuscript proofed by an outside individual before it is resubmitted. Both reviewers have also provided helpful comments. Response: Thanks for your comments. Following the reviewers’ comments, we have revised the manuscript carefully. In order to enhance the writing, a well-known outside professional editing institution has assisted us in improving the English writing of our manuscript with charges., which has substantially improved the quality of the paper. Response to Comments of Reviewer 1 Comments: This toned-down manuscript with a more accurate title is much improved. It might be helpful to have a reader fluent in English correct some of the minor grammatical and style errors, even though the narrative is easy to follow and is readily comprehensible. Overall, the paper sends a reassuring message to women confined to home during a pandemic. Respond: Thanks for your positive comments with respect to our previous revision. In this round of revision, a professional institution has helped us in improving the English writing. Response to Comments of Reviewer 2 Q1:There are still a number of problems with the English. It was recommended in the initial review that the authors consider using this type of service, or get some other editorial help from a native English speaker. Just a few of the types of problems that occur in the manuscript are listed below; this is by no means a complete list. Line 114: you cannot start a sentence with a numeral in English. Line 120: SCORES Line 155: you cannot start a sentence with a numeral in English. Line 197: change “pregnant women were trapped in their homes” to “pregnant women were confined to their homes” Line 197-198: change “and it was not convenient for them to go out for taking a walk.” To “and their ability to exercise was limited.” Response: Thanks for your comments. In the revised manuscript, we have corrected all the mistakes you pointed out. In addition, a well-known professional institution has helped us in improving the overall English writing. Q2. Tables 1, 3 and 4: The authors should review rules on significant digits. It does not seem correct to show the percentage values with two places to the right of the decimal. Would not whole percentages perhaps be better? Respond:According to your comments, we have reviewed the papers with respect to retrospective study published on PLOS ONE, which have been listed below. We decide the follow their rules on significant digits and also the percentage values. The corresponding tables Tables 1, 3 and 4 have been revised carefully. Chu S, Chen Q, Chen Y, et al. Cesarean section without medical indication and risk of childhood asthma, and attenuation by breastfeeding[J]. PLoS One, 2017, 12(9): e0184920. 28 Jul 2020 Impact of Wuhan lockdown on the indications of cesarean delivery and newborn weights during the epidemic period of COVID-19 PONE-D-20-12899R1 Dear Dr. Zhao, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Cheryl S. Rosenfeld, DVM, PhD Section Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper is now suitable for publication. The written English is much improved and the the conclusions suitably muted. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No 3 Aug 2020 PONE-D-20-12899R1 Impact of Wuhan lockdown on the indications of cesarean delivery and newborn weights during the epidemic period of COVID-19 Dear Dr. Zhao: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Cheryl S. Rosenfeld Section Editor PLOS ONE
  14 in total

Review 1.  Prenatal nutrition and birth outcomes.

Authors:  Eileen R Fowles
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2004 Nov-Dec

2.  Prenatal exposure to maternal smoking and childhood behavioural problems: a quasi-experimental approach.

Authors:  Cathal McCrory; Richard Layte
Journal:  J Abnorm Child Psychol       Date:  2012-11

3.  Prenatal Nutrition Education: Updates and Best Practices for Optimal Diet and Weight Gain during Pregnancy.

Authors:  Anna Maria Siega-Riz; Leeza Constantoulakis
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2019-11-28

4.  Diagnosis of birth asphyxia on the basis of fetal pH, Apgar score, and newborn cerebral dysfunction.

Authors:  L C Gilstrap; K J Leveno; J Burris; M L Williams; B B Little
Journal:  Am J Obstet Gynecol       Date:  1989-09       Impact factor: 8.661

5.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

6.  What are the risks of COVID-19 infection in pregnant women?

Authors:  Jie Qiao
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

7.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.

Authors:  Huijun Chen; Juanjuan Guo; Chen Wang; Fan Luo; Xuechen Yu; Wei Zhang; Jiafu Li; Dongchi Zhao; Dan Xu; Qing Gong; Jing Liao; Huixia Yang; Wei Hou; Yuanzhen Zhang
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

8.  A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome.

Authors:  Chui Miu Lam; Shell Fean Wong; Tse Ngong Leung; Kam Ming Chow; Wai Cho Yu; Tin Yau Wong; Sik To Lai; Lau Cheung Ho
Journal:  BJOG       Date:  2004-08       Impact factor: 6.531

9.  Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome.

Authors:  Shell F Wong; Kam M Chow; Tse N Leung; Wai F Ng; Tak K Ng; Chi C Shek; Pak C Ng; Pansy W Y Lam; Lau C Ho; William W K To; Sik T Lai; Wing W Yan; Peggy Y H Tan
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

10.  Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection.

Authors:  Dunjin Chen; Huixia Yang; Yun Cao; Weiwei Cheng; Tao Duan; Cuifang Fan; Shangrong Fan; Ling Feng; Yuanmei Gao; Fang He; Jing He; Yali Hu; Yi Jiang; Yimin Li; Jiafu Li; Xiaotian Li; Xuelan Li; Kangguang Lin; Caixia Liu; Juntao Liu; Xinghui Liu; Xingfei Pan; Qiumei Pang; Meihua Pu; Hongbo Qi; Chunyan Shi; Yu Sun; Jingxia Sun; Xietong Wang; Yichun Wang; Zilian Wang; Zhijian Wang; Chen Wang; Suqiu Wu; Hong Xin; Jianying Yan; Yangyu Zhao; Jun Zheng; Yihua Zhou; Li Zou; Yingchun Zeng; Yuanzhen Zhang; Xiaoming Guan
Journal:  Int J Gynaecol Obstet       Date:  2020-04-01       Impact factor: 4.447

View more
  17 in total

1.  Impact of the COVID-19 pandemic on neonatal admissions in a tertiary children's hospital in southwest China: An interrupted time-series study.

Authors:  Weiqin Liu; Qifen Yang; Zhen-E Xu; Ya Hu; Yongming Wang; Zhenqiu Liu; Qianqian Zhao; Zhuangcheng Wang; Hong Wei; Ziyu Hua
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

2.  Changes in prenatal care and vaccine willingness among pregnant women during the COVID-19 pandemic.

Authors:  Daniel J Erchick; Smisha Agarwal; Alexander Kaysin; Dustin G Gibson; Alain B Labrique
Journal:  BMC Pregnancy Childbirth       Date:  2022-07-13       Impact factor: 3.105

3.  Pregnancy Outcome during the First COVID 19 Lockdown in Vienna, Austria.

Authors:  Sylvia Kirchengast; Beda Hartmann
Journal:  Int J Environ Res Public Health       Date:  2021-04-05       Impact factor: 4.614

4.  COVID-19 pandemic and population-level pregnancy and neonatal outcomes: a living systematic review and meta-analysis.

Authors:  Jie Yang; Rohan D'Souza; Ashraf Kharrat; Deshayne B Fell; John W Snelgrove; Kellie E Murphy; Prakesh S Shah
Journal:  Acta Obstet Gynecol Scand       Date:  2021-06-28       Impact factor: 4.544

5.  Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis.

Authors:  Barbara Chmielewska; Imogen Barratt; Rosemary Townsend; Erkan Kalafat; Jan van der Meulen; Ipek Gurol-Urganci; Pat O'Brien; Edward Morris; Tim Draycott; Shakila Thangaratinam; Kirsty Le Doare; Shamez Ladhani; Peter von Dadelszen; Laura Magee; Asma Khalil
Journal:  Lancet Glob Health       Date:  2021-03-31       Impact factor: 26.763

6.  Clinical Effects of the COVID-19 Pandemic Among the Uninfected Pregnant Women - 6 PLADs, China, 2019-2020.

Authors:  Bin Wang; Hang An; Huanqing Hu; Wei Zhao; Bahabaike Jiangtulu; Shuo Wang; Jiamei Wang; Junxi Chen; Manman Long; Zewu Li; Yu Jin; Yuhuan Li; Huiting Chen; Tao Xue; Xiqing Li; Kexin Li; Wei Du; Suhong Gao; Jiangli Di; Xiaohong Liu; Rongwei Ye; Zhiwen Li
Journal:  China CDC Wkly       Date:  2021-03-05

7.  Coronavirus disease 2019 pandemic and pregnancy and neonatal outcomes in general population: A living systematic review and meta-analysis (updated Aug 14, 2021).

Authors:  Jie Yang; Rohan D'Souza; Ashraf Kharrat; Deshayne B Fell; John W Snelgrove; Kellie E Murphy; Prakesh S Shah
Journal:  Acta Obstet Gynecol Scand       Date:  2021-11-03       Impact factor: 4.544

8.  Coordinated Management of COVID-19 Response: Lessons From Whole-of-Society and Whole-of-Health Strategies in Wuhan, China.

Authors:  Shanquan Chen; Pan Zhang; Yun Zhang; Hong Fung; Yong Han; Chi Kin Law; Zhiqiang Li
Journal:  Front Public Health       Date:  2021-08-03

Review 9.  Impact of lockdown and school closure on children's health and well-being during the first wave of COVID-19: a narrative review.

Authors:  Luis Rajmil; Anders Hjern; Perran Boran; Geir Gunnlaugsson; Olaf Kraus de Camargo; Shanti Raman
Journal:  BMJ Paediatr Open       Date:  2021-05-25

10.  Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.

Authors:  John Allotey; Elena Stallings; Mercedes Bonet; Magnus Yap; Shaunak Chatterjee; Tania Kew; Luke Debenham; Anna Clavé Llavall; Anushka Dixit; Dengyi Zhou; Rishab Balaji; Siang Ing Lee; Xiu Qiu; Mingyang Yuan; Dyuti Coomar; Jameela Sheikh; Heidi Lawson; Kehkashan Ansari; Madelon van Wely; Elizabeth van Leeuwen; Elena Kostova; Heinke Kunst; Asma Khalil; Simon Tiberi; Vanessa Brizuela; Nathalie Broutet; Edna Kara; Caron Rahn Kim; Anna Thorson; Olufemi T Oladapo; Lynne Mofenson; Javier Zamora; Shakila Thangaratinam
Journal:  BMJ       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.